BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19761421)

  • 1. Clinical and biological diversity of splenic marginal zone lymphoma.
    Matutes E
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1185-9. PubMed ID: 19761421
    [No Abstract]   [Full Text] [Related]  

  • 2. [Splenic marginal zone lymphoma].
    Dimopoulos K; Pedersen M
    Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H; Hawley I; Beard J
    Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
    Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
    Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
    Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
    Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
    Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
    Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic marginal zone lymphoma in a patient with chronic hepatitis B.
    Christou L; Kalambokis G; Bai M; Kamina S; Tsianos EV
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):511-2. PubMed ID: 20076834
    [No Abstract]   [Full Text] [Related]  

  • 9. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
    Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
    Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Splenic pathology. Case no 2. Splenic marginal zone B-cell lymphoma].
    Traverse-Glehen A; Berger F
    Ann Pathol; 2010 Jun; 30(3):206-10. PubMed ID: 20621598
    [No Abstract]   [Full Text] [Related]  

  • 11. Marginal zone lymphomas, MALT and splenic types.
    De Wolf-Peeters C
    Adv Clin Path; 2000 Oct; 4(4):190-2. PubMed ID: 11436156
    [No Abstract]   [Full Text] [Related]  

  • 12. Splenic marginal zone lymphoma in 5 dogs (2001-2008).
    Stefanello D; Valenti P; Zini E; Comazzi S; Gelain ME; Roccabianca P; Avallone G; Caniatti M; Marconato L
    J Vet Intern Med; 2011; 25(1):90-3. PubMed ID: 21092007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-MALT marginal zone lymphomas.
    Thieblemont C
    Ann Oncol; 2008 Jun; 19 Suppl 4():iv70-3. PubMed ID: 18519410
    [No Abstract]   [Full Text] [Related]  

  • 14. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.
    Matutes E; Oscier D; Montalban C; Berger F; Callet-Bauchu E; Dogan A; Felman P; Franco V; Iannitto E; Mollejo M; Papadaki T; Remstein ED; Salar A; Solé F; Stamatopoulos K; Thieblemont C; Traverse-Glehen A; Wotherspoon A; Coiffier B; Piris MA
    Leukemia; 2008 Mar; 22(3):487-95. PubMed ID: 18094718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy--a therapeutic option in splenic marginal zone cell lymphoma.
    Vlădăreanu AM; Onisâi M; Ciufu C; Bumbea H; Cîşleanu D; Voican I; Nicolescu A; Radeşi S; Vintilescu A; Băluţă C; Dobrea C; Savlovschi C; Grecu L; Serban D; Serafim G
    Rom J Intern Med; 2009; 47(2):191-9. PubMed ID: 20067170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudo-faggot cells in splenic marginal zone lymphoma.
    Wilson J
    Br J Haematol; 2023 Apr; 201(1):7. PubMed ID: 36606572
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of marginal zone lymphoma.
    Reid R; Friedberg JW
    Oncology (Williston Park); 2013 Sep; 27(9):840, 842, 844. PubMed ID: 24282977
    [No Abstract]   [Full Text] [Related]  

  • 19. Splenic lymphomas: is there still a role for splenectomy?
    Martin P; Rutherford S; Leonard JP
    Oncology (Williston Park); 2012 Feb; 26(2):204, 206. PubMed ID: 22489357
    [No Abstract]   [Full Text] [Related]  

  • 20. Marginal zone lymphomas.
    Zucca E; Bertoni F; Stathis A; Cavalli F
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):883-901, viii. PubMed ID: 18954742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.